Reduction of adverse effects by systemic antihistamines during therapy with fumarates in severe chronic plaque psoriasis.
Recruiting
- Conditions
- Psoriasis vulgaris
- Registration Number
- NL-OMON20745
- Lead Sponsor
- Erasmus Medical Center Rotterdam, Departement of Dermatology
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. Patients with known severe psoriasis of the chronic plaque type
2. PASI > 10
Exclusion Criteria
1. Pregnancy and breast feeding
2. Patients with Prostate hyperplasia, Glaucoma, Stomach ulcer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PASI-score
- Secondary Outcome Measures
Name Time Method skin-biopsies